Arkolith/Insider Trading/BDSX/Form 4

O'Kane Kieran

Chief Commercial OfficerBIODESIX INC (BDSX) · full profile →Form 4 · filed Nov 13, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$191
Net Open-Market Flow
-$190
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 10, 2025Option exercise(M)75——7K
Nov 10, 2025Sell(S)25$7.62$1917K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 10, 2025Option exercise(M)75—$073

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000905148-25-003931) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML